| ActivX Biosciences News (2003-2004) |
 |
| Wednesday, March 21, 2007 |
| ActivX Biosciences Launches Breakthrough Kinase Platform, KiNativ Posted 6:34 AM PST |
| |
| Thursday, March 1, 2007 |
| SAN DIEGO--- Ligand Announces Changes and Additions to the Board of Directors Posted 4:54 PM PST |
| |
| Wednesday, March 15, 2006 |
| ActivX/Kyorin Begins First U.S. Phase I Study for Novel Anti-Diabetic Drug Posted 8:07 AM PST |
| |
| Tuesday, March 14, 2006 |
| ActivX Biosciences Announces Expansion of Strategic Collaboration Agreement With Pfizer Inc. With Multiple Discovery and Developmental Stage Projects Posted 8:31 AM PST |
| |
| Wednesday, February 9, 2005 |
| ActivX Biosciences Announces Expansion of Strategic Collaboration Agreement with Pfizer Inc. with Multiple Discovery and Developmental Stage Projects Posted 7:09 PM PST |
| |
| Wednesday, February 2, 2005 |
| LA JOLLA--- ActivX Biosciences Announces Closing of Acquisition by Kyorin Pharmaceutical Co., Ltd. Posted 10:51 AM PST |
| |
| Tuesday, April 6, 2004 |
| ActivX Biosciences Announces Agreement with Gilead Sciences for Protein Activity Profiling Posted 10:52 AM PST |
| |
| Tuesday, January 13, 2004 |
| ActivX Biosciences and Kyorin Pharmaceutical Sign Second Drug Discovery and Development Collaboration Agreement Posted 8:48 AM PST |
| |
| Tuesday, November 18, 2003 |
| LA JOLLA--- ActivX Biosciences Appoints James A. Schoeneck Chief Executive Officer; Dr. John W. Kozarich Assumes Role of President and Chief Research and Development Officer Posted 4:26 PM PST |
| |
| Monday, May 5, 2003 |
| LA JOLLA--- ActivX Biosciences Appoints J.C. MacRae Executive Vice President and Chief Financial Officer Posted 7:49 AM PST |
| |
| Wednesday, March 26, 2003 |
| ActivX Biosciences Reports Key Advances on the Large-Scale Profiling of Kinases and Other Nucleotide Binding Proteins Posted 7:50 AM PST |
| |
| Thursday, March 6, 2003 |
| SAN DIEGO--- John W. Kozarich Elected to Ligand Board of Directors Posted 6:00 PM PST |
| |
| Wednesday, February 19, 2003 |
| LA JOLLA--- ActivX Biosciences Promotes David A. Campbell, Ph.D., to New Position to Lead Medicinal Chemistry Programs Posted 8:08 AM PST |
| |
| Monday, January 6, 2003 |
| ActivX Biosciences and Sosei to Collaborate on Drug Re-profiling Program Posted 8:13 AM PST |
| |
